Barclays raised the firm’s price target on Eaton to $250 from $220 and keeps an Underweight rating on the shares. The analyst increased estimates post the Q4 report. The firm thought declines in Electrical orders would weigh on the Eaton’s valuation multiple as earnings momentum started to slow. However, the ongoing positive estimate revision cycle that is driven by ongoing strong sales momentum has pushed the issue of orders moderation into the background, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ETN:
- Eaton price target raised to $246 from $220 at RBC Capital
- Correction: Eton Pharmaceuticals announces availability of Nitisinone Capsules
- Eaton announces availability of Nitisinone Capsules
- Eaton price target raised to $300 from $260 at Mizuho
- Eaton price target raised to $310 from $270 at Citi
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue